Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

D-xylose kinetics (absorption, excretion and distribution); oral (drinking water) and intravenous; 10 human patients (male/female) with impaired renal function was examined.

Additional information

D-xylose kinetics was studied after oral administration of 25 grams D-xylose to 10 patients with impaired renal function, three of whom were being evaluated for intestinal malabsorption. The 0.32 ± 0.06 L/kg (mean ± SD) distribution volume of D-xylose in patients with uncomplicated renal impairment was larger than the value of 0.23 ± 0.04 L/kg that the authors reported previously for normal subjects (P < 0.01). Renal clearance was also reduced, averaging 87% of glomerular filtration rate estimated from creatinine clearance, so that the elimination-phase half-life was prolonged to 138 ± 39 minutes from 75 ± 11 minutes in normal individuals (P < 0.01). The 25 g oral D-xylose dose was 77.4% ± 14.8% absorbed in the patients with uncomplicated renal impairment, similar to the 69.4% ± 13.6% absorption reported in normal individuals. However, the absorption half-life was prolonged from 31 ± 12 minutes in normal subjects to a value of 62 ± 23 minutes (P < 0.02). Of the usual clinical indexes of D-xylose absorption, the serum concentration measured 1 hour after the oral dose was best correlated with the extent of D-xylose absorption (r = 0.76; P < 0.01), and the standard lower normal limit of 0.2 mg/mL was satisfactory.